Search the Newsreel

Amphenol Corporation presenta sus resultados del segundo trimestre y del primer semestre de 2026

Amphenol (APH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Amphenol (APH) reported $8.76 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 55%. EPS of $1.35 for the same period compares to $0.81 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $8.3 billion, …

Amphenol (APH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

The price trend for Amphenol (APH) has been bearish lately and the stock has lost 8.9% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as …

Amphenol Beats Second-Quarter Forecasts as AI Demand Fuels Growth and Outlook Improves

Technology network ©Adobe Stock Images Amphenol Corporation (NYSE:APH) reported stronger-than-expected second-quarter results and issued an upbeat third-quarter outlook, driven by robust demand for AI-related data communications products and contributions from recent acquisitions. The company's shares rose around 7% in premarket trading following the announcement. …

Amphenol (APH) Beats Q2 Earnings and Revenue Estimates

Amphenol (APH) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $0.81 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Amphenol surges after Q2 results, Q3 outlook beat estimates

[Fiber Optics Cable] peterschreiber.media/iStock via Getty Images Shares of Amphenol (APH [https://seekingalpha.com/symbol/APH]) surged about 9% on Wednesday after second quarter results and third quarter outlook beat estimates. For the second quarter, Amphenol — which makes fiber optic connectors — saw adjusted EPS surge 67% …

Amphenol beats Q2 estimates, raises Q3 outlook on AI-driven demand

Investing.com -- Amphenol topped Wall Street expectations for the second quarter and issued stronger-than-expected third-quarter guidance on Wednesday, as robust AI-driven demand for IT datacom products and contributions from acquisitions lifted results. Shares rose about 7% in premarket trading. The connector manufacturer reported adjusted …

AMPHENOL ($APH) Releases Q2 2026 Earnings

This article first appeared on GuruFocus. Revenue: Record sales of $8.8 billion, up 55% in US dollars, 54% in local currencies, and 30% organically year-over-year. Orders: Record orders of $10.732 billion, up 94% year-over-year, with a book-to-bill ratio of 1.23:1. Adjusted Operating Margin: Record …

Amphenol (NYSE:APH) Surprises With Strong Q2 CY2026, Stock Soars

Amphenol (NYSE:APH) Surprises With Strong Q2 CY2026, Stock Soars Electrical connector manufacturer Amphenol (NYSE:APH) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 55% year on year to $8.76 billion. On top of that, next quarter's revenue guidance ($9.35 billion …

Amphenol Reports Record Second Quarter 2026 Results

Second Quarter 2026 Highlights: Sales of $8.8 billion, up 55% in U.S. dollars and 30% organically compared to the second quarter of 2025 Orders of $10.7 billion, resulting in a book-to-bill of 1.23:1 GAAP Diluted EPS of $1.37, up 59% compared to prior year …

Amphastar Sets Aug. 6 Webcast for Second-Quarter Results

Amphastar Pharmaceuticals (NASDAQ: AMPH) announced it will release its second-quarter 2026 financial results on Thursday, August 6, 2026, after the market closes. The company will also host a conference call at 2:00 p.m. Pacific Time to discuss the results, with access available via dial-in …

Amphenol (APH) Stock Sees Modest Fair Value Lift After Analyst Target Increases

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Amphenol is back in focus after analysts raised their fair value estimate from US$184.78 to US$189.39, pointing to a slightly higher price target framework for the stock. …

Earnings To Watch: Amphenol (APH) Reports Q2 Results Tomorrow

Amphastar Pharmaceuticals Inc (AMPH) Cash Flow

This article provides a detailed cash flow statement for Amphastar Pharmaceuticals Inc (AMPH), covering annual and quarterly data across operating, investing, and financing activities. It presents financial figures for various cash flow components from FY2012Q4 to FY2026Q1, including net income, capital expenditures, and changes …

Amphenol Corporation (APH) Regains Appeal on an Improved Growth Outlook

Jensen Investment Management, an asset management company based in the US, released its second-quarter 2026 investor letter for the "Jensen Quality Growth Equity Strategy". A copy of the letter is available to download here. The fund seeks long-term growth by investing in high-quality companies …

Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Amphastar Pharmaceuticals Inc (AMPH), listing major shareholders such as Applied Physics & Chemistry Laboratories, Inc., BlackRock Institutional Trust Company, N.A., and key individual investors. It also provides a breakdown of shareholder types, institutional holdings over several quarters, …

3 Reasons AMPH is Risky and 1 Stock to Buy Instead

Amphastar Pharmaceuticals (AMPH) has seen its stock price drop significantly, leading to questions about its investment potential. The article highlights three reasons for caution: lackluster revenue growth, limited distribution channels due to its small size in a scale-driven industry, and a shrinking adjusted operating …

Is Amphenol Stock a Smart Buy Before Q2 Earnings Report?

Why Amphenol (APH) Stock Is Down Today

Amphastar Pharmaceuticals Inc (AMPH) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Amphastar Pharmaceuticals Inc (AMPH) focusing on its dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years, indicating no recent payouts. The page also displays current stock price …

AMPH|Amphastar Pharmaceuticals Inc|Price:19.180|Chg%:+0.460

This article provides a comprehensive stock analysis of Amphastar Pharmaceuticals Inc (AMPH) by TradingKey. It highlights the company's relatively healthy fundamentals, high growth potential, and fair valuation within the Pharmaceuticals industry. While institutional ownership is very high and analysts generally rate it as a …

Amphastar Pharmaceuticals Inc (AMPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Amphastar Pharmaceuticals Inc (AMPH), categorizing it by business segments and regional contributions. Key product revenues are highlighted, such as Other products, BAQSIMI, Primatene Mist, Epinephrine, and Glucagon. The dominant source of regional revenue for AMPH is …

Is Amphenol (APH) Undervalued On Strong Earnings Expectations?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Anticipation around Amphenol (APH) is building, as analysts widely expect the upcoming quarterly report to show strong year over year growth in both earnings and revenue, supported …

Insights Into Amphenol (APH) Q2: Wall Street Projections for Key Metrics

In its upcoming report, Amphenol (APH) is predicted by Wall Street analysts to post quarterly earnings of $1.19 per share, reflecting an increase of 46.9% compared to the same period last year. Revenues are forecasted to be $8.3 billion, representing a year-over-year increase of …

AI Sales are a Huge Catalyst for Amphenol Shares

APH designs, manufactures, and markets electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products, as well as specialty cables. Its first-quarter fiscal 2026 earnings report showed record sales of $7.6 billion (a 33% year-over-year gain), adjusted diluted per-share earnings of …

Amphenol Corp (APH), a High-Quality Company, Strengthens From AI Infrastructure Buildout

Brasada Capital Management, an investment management company, released its Q2 2026 investor letter. A copy of the letter is available to download here. The market landscape in the past quarter has been significantly influenced by the rapid advancements in artificial intelligence (AI), overshadowing other …

AMPH5896384 Bond Coupon Profile — Rate & Payments

This article provides the coupon profile for the Amphastar Pharmaceuticals, Inc. bond, identified as AMPH5896384. It details that the bond has a current coupon rate of 2.00% and the next interest payment is scheduled for September 15, 2026. The information covers the bond's nominal …

Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by Zacks Research to "Hold" Rating

Zacks Research upgraded Amphastar Pharmaceuticals

APHU ETF Profile: Dividends, Returns (BOATS:APHU)

The APHU ETF, T-REX 2X Long APH Daily Target ETF, aims for a daily leveraged exposure of 200% to the Amphenol Corporation (APH) stock through swap agreements and listed call options. Issued by Tuttle Capital Management LLC, the ETF was launched on February 18, …

Amphenol (APH) Stock May Be Slightly Rich As AI Demand Builds

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. After a very strong 5 year run, Amphenol's share price now sits in a zone where the Discounted Cash Flow (DCF) intrinsic value …

Amphenol (APH) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Amphenol (APH) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence …

Quantedge Capital Pte Ltd Sells 78,200 Shares of Amphastar Pharmaceuticals, Inc. $AMPH

Quantedge Capital Pte Ltd significantly reduced its stake in Amphastar Pharmaceuticals, Inc. by 85.3% in the first quarter, selling 78,200 shares. This move leaves the firm with 13,500 shares valued at $264,000, following Amphastar's Q1 earnings miss and Wall Street's cautious "Reduce" rating with …

US3209RAB9 Bond Profile — Key Metrics

This article provides key metrics for the US3209RAB9 bond issued by Amphastar Pharmaceuticals, Inc. It details the bond's coupon rate, issue and maturity dates, outstanding amount, and face value. The profile also includes a brief description of Amphastar Pharmaceuticals, Inc. and its business operations.

Here's How Much $100 Invested In Amphenol 5 Years Ago Would Be Worth Today

Amphenol (NYSE: APH) has demonstrated strong market outperformance over the last five years, with an annualized return of 34.54%. An investment of $100 in APH five years ago would now be worth $448.73, highlighting the significant impact of compounded returns. The article emphasizes the …

Amphenol Corporation (APH) builds momentum as weekly trend stays active

The electronic-components maker is extending a multiweek advance in weekly context, with momentum readings supportive but volume still below recent norms.

Amphenol’s 10.8% week lifts it 10.6% above trend, while the Trend Signal remains inactive

APH staged a sharp weekly recovery on above-average volume, but Sharemaestro’s signal stack still treats the move as early confirmation rather than a completed regime shift.